153 related articles for article (PubMed ID: 22990801)
21. Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents.
Sanchez BA; Mota MM; Sultan AA; Carvalho LH
Int J Parasitol; 2004 Mar; 34(4):485-90. PubMed ID: 15013738
[TBL] [Abstract][Full Text] [Related]
22. A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
Delves MJ; Ramakrishnan C; Blagborough AM; Leroy D; Wells TN; Sinden RE
Int J Parasitol; 2012 Oct; 42(11):999-1006. PubMed ID: 23023046
[TBL] [Abstract][Full Text] [Related]
23. Selective accumulation of a novel antimalarial rhodacyanine derivative, SSJ-127, in an organelle of Plasmodium berghei.
Ikegami-Kawai M; Arai C; Ogawa Y; Yanoshita R; Ihara M
Bioorg Med Chem; 2010 Nov; 18(22):7804-8. PubMed ID: 20970347
[TBL] [Abstract][Full Text] [Related]
24. Small-scale in vitro culture and purification of Plasmodium berghei for transfection experiment.
Somsak V; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Mol Biochem Parasitol; 2011 Jun; 177(2):156-9. PubMed ID: 21291917
[TBL] [Abstract][Full Text] [Related]
25. 4(1H)-Quinolones with liver stage activity against Plasmodium berghei.
Lacrue AN; Sáenz FE; Cross RM; Udenze KO; Monastyrskyi A; Stein S; Mutka TS; Manetsch R; Kyle DE
Antimicrob Agents Chemother; 2013 Jan; 57(1):417-24. PubMed ID: 23129047
[TBL] [Abstract][Full Text] [Related]
26. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.
Chang ZW; Malleret B; Russell B; Rénia L; Claser C
Antimicrob Agents Chemother; 2016 Nov; 60(11):6859-6866. PubMed ID: 27600050
[TBL] [Abstract][Full Text] [Related]
27. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
28. Laboratory maintenance of rodent malaria parasites.
Ramakrishnan C; Delves MJ; Lal K; Blagborough AM; Butcher G; Baker KW; Sinden RE
Methods Mol Biol; 2013; 923():51-72. PubMed ID: 22990771
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium berghei: antiparasitic effects of orally administered hypoestoxide in mice.
Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Oyemade OA; Adesomoju AA; Okogun JI
Exp Parasitol; 2007 Oct; 117(2):218-21. PubMed ID: 17568581
[TBL] [Abstract][Full Text] [Related]
30. [Effect of daphnetin on the exo-erythrocytic stage of rodent malaria].
Liu YG; Wang QM; Xu YQ; Ni QZ; Ni YC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(1):30-2. PubMed ID: 12572020
[TBL] [Abstract][Full Text] [Related]
31. Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites.
Carrasco MP; Machado M; Gonçalves L; Sharma M; Gut J; Lukens AK; Wirth DF; André V; Duarte MT; Guedes RC; Dos Santos DJ; Rosenthal PJ; Mazitschek R; Prudêncio M; Moreira R
ChemMedChem; 2016 Oct; 11(19):2194-2204. PubMed ID: 27538856
[TBL] [Abstract][Full Text] [Related]
32. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
33. The schizontocidal activity of daphnetin against malaria parasites in vitro and in vivo.
Wang QM; Ni YC; Xu YQ; Ha SH; Cai Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):204-6. PubMed ID: 12567659
[TBL] [Abstract][Full Text] [Related]
34. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
35. Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development.
de Koning-Ward TF; Drew DR; Chesson JM; Beeson JG; Crabb BS
Mol Biochem Parasitol; 2008 May; 159(1):69-72. PubMed ID: 18359107
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of bioluminescence-based assays of anti-malarial drug activity.
Hasenkamp S; Sidaway A; Devine O; Roye R; Horrocks P
Malar J; 2013 Feb; 12():58. PubMed ID: 23394077
[TBL] [Abstract][Full Text] [Related]
37. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R
ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585
[TBL] [Abstract][Full Text] [Related]
38. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Ishih A; Suzuki T; Watanabe M; Miyase T; Terada M
Phytother Res; 2003 Dec; 17(10):1234-6. PubMed ID: 14669265
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
[TBL] [Abstract][Full Text] [Related]
40. Antimalarial activity of 1-aryl-3,3-dialkyltriazenes.
Nishiwaki K; Okamoto A; Matsuo K; Kawaguchi Y; Hayase Y; Ohba K
Bioorg Med Chem; 2007 Apr; 15(8):2856-9. PubMed ID: 17329108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
